| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Induced ERK1/2 Activation and Promotion of Migration and Invasion of Esophageal Cancer Cells
Departments of Microbiology and Immunology, and Biochemistry and Molecular Biology, Virginia Commonwealth University School of Medicine, Richmond, VA
* To whom correspondence should be addressed. Email: dlebman{at}vcu.edu.
| Abstract |
|---|
TGF
plays a dual role in oncogenesis acting as both a tumor suppressor and a tumor promoter. These disparate processes are mediated primarily by Smad and non-Smad signaling, respectively. A central issue in understanding the role of TGF
in the progression of epithelial cancers is elucidation of the mechanisms underlying activation of non-Smad signaling cascades. Because the potent lipid mediator sphingosine-1-phosphate has been shown to transactivate the TGF
receptor and activate Smad3, we examined its role in TGF
activation of ERK1/2 and promotion of migration and invasion of esophageal cancer cells. Both S1P and TGF
activate ERK1/2, but only TGF
activates Smad3. Both ligands promoted ERK1/2-dependent migration and invasion. Furthermore, TGF
rapidly increased S1P, which was required for TGF
induced ERK1/2 activation as well as migration and invasion since downregulation of sphingosine kinases, the enzymes that produce S1P, inhibited these responses. Finally, our data demonstrate that TGF
activation of ERK1/2 as well as induction of migration and invasion is mediated at least in part by ligation of the S1P receptor, S1P2. Thus, these studies provide the first evidence that TGF
activation of sphingosine kinases and formation of S1P contribute to non-Smad signaling and could be important for progression of esophageal cancer.
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|